STOP AF First Post-Approval Study
STOP AF First Post-Approval Study, an Addendum to the Cryo Global Registry
Sponsor: Medtronic Cardiac Ablation Solutions
This observational or N/A phase trial investigates Paroxysmal Atrial Fibrillation and is currently actively recruiting participants. Medtronic Cardiac Ablation Solutions leads this study, which shows 18 recorded versions since 2022 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
18 versions recorded-
Dec 2025 — Present [monthly]
Recruiting
-
Sep 2025 — Dec 2025 [monthly]
Recruiting
-
May 2025 — Sep 2025 [monthly]
Recruiting
-
Mar 2025 — May 2025 [monthly]
Recruiting
-
Jan 2025 — Mar 2025 [monthly]
Recruiting
▶ Show 13 earlier versions
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2024 — Jul 2024 [monthly]
Recruiting
-
Feb 2024 — May 2024 [monthly]
Recruiting
-
Nov 2023 — Feb 2024 [monthly]
Recruiting
-
Aug 2023 — Nov 2023 [monthly]
Recruiting
-
May 2023 — Aug 2023 [monthly]
Recruiting
-
Mar 2023 — May 2023 [monthly]
Recruiting
-
Feb 2023 — Mar 2023 [monthly]
Recruiting
-
Nov 2022 — Feb 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
May 2022 — Nov 2022 [monthly]
Not Yet Recruiting
-
Apr 2022 — May 2022 [monthly]
Not Yet Recruiting
-
Mar 2022 — Apr 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Cardiac Ablation Solutions
For direct contact, visit the study record on ClinicalTrials.gov .